| In
2005, the US Food and Drug Administration (FDA)
approved PEGASYS for the treatment of chronic
hepatitis B. Already the most prescribed hepatitis
C medication in the United States, PEGASYS is
the first and only
pegylated interferon approved for the treatment
of chronic hepatitis B, including both main types
of the virus.
PEGASYS
helps in two important ways:
-
PEGASYS slows replication of the hepatitis
B virus.
- PEGASYS boosts the body's immune system.
Pegasys
Product Information
(Pegasys for treatment of Hepatitis B starts
on page 25 of PDF)
HBV
Pegasys Roche Web Page
|
Articles on Pegasys (peginterferon alfa-2a) for Treatment
of Hepatitis B
